Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1306 Views
-
Last post by frodo
-
- 0 Replies
- 967 Views
-
Last post by frodo
-
- 0 Replies
- 2302 Views
-
Last post by NHE
-
- 0 Replies
- 1273 Views
-
Last post by frodo
-
- 0 Replies
- 1228 Views
-
Last post by frodo
-
- 0 Replies
- 1189 Views
-
Last post by frodo
-
- 0 Replies
- 1448 Views
-
Last post by NHE
-
- 0 Replies
- 470 Views
-
Last post by NHE
-
- 1 Replies
- 2911 Views
-
Last post by Tif